Table 2.
Meta-analysis of selected studies.
| Variables | No of stuides | Sample Size | Pooled Proportion | 95% CI(lower limit- Upper Limit) | Q | I2% |
|---|---|---|---|---|---|---|
| Hypertension | 14 | 376 | 0.7195 | 0.6692–0.7648 | 10.86 | 0.0 |
| Diabetes Mellitus | 11 | 370 | 0.4002 | 0.3080–0.5001 | 18.39 | 45.6 |
| Dyslipidemia | 9 | 213 | 0.5887 | 0.3935–0.7595 | 34.07 | 76.5 |
| Pre-existing coronary artery disease(CAd) | 8 | 330 | 0.2929 | 0.1370–0.5196 | 73.93 | 90.5 |
| Dyspnea | 11 | 248 | 0.6105 | 0.4708–0.7341 | 19.51 | 48.7 |
| Chest Pain | 11 | 241 | 0.5996 | 0.4175–0.7578 | 45.87 | 78.2 |
| Fever | 8 | 215 | 0.5561 | 0.3994–0.7025 | 11.13 | 37.1 |
| Smoking | 8 | 277 | 0.3945 | 0.2648–0.5410 | 13.24 | 47.1 |
| Obstructive CAD | 12 | 370 | 0.6180 | 0.3854–0.8068 | 59.65 | 81.6 |
| Non-Obstructive CAD | 6 | 77 | 0.4812 | 0.3476–0.6175 | 4.28 | 0.0 |
| PCI | 12 | 222 | 0.6437 | 0.3870–0.8380 | 53.81 | 79.6 |
| Fibrinolysis | 3 | 100 | 0.3962 | 0.0040–0.9900 | 14.68 | 86.4 |
| Mortality | 12 | 372 | 0.3420 | 0.2202–0.4889 | 35.14 | 68.7 |